CORONA Remedies Limited (NSE:CORONA)

India · Delayed Price · Currency is INR

1,750.60

+18.90 (1.09%)

At close: Jun 16, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Pharmaceuticals	14.03B	11.96B	10.14B	8.84B	6.17B
Pharmaceuticals Growth	17.28%	17.93%	14.75%	43.21%	7.14%
Total	14.03B	11.96B	10.14B	8.84B	6.17B
Total Growth	17.28%	17.93%	14.75%	43.21%	7.14%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
India	11.52B	9.80B	8.52B	5.95B
India Growth	17.57%	15.03%	43.19%	-
outside India	439.59M	342.46M	318.89M	221.88M
outside India Growth	28.36%	7.39%	43.72%	-
Total	11.96B	10.14B	8.84B	6.17B
Total Growth	17.93%	14.75%	43.21%	-